Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cancer Science|April 4, 2008
Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: prognostic factors and unique toxicity profileYutaka Hattori, Shin-ichiro Okamoto, Naoki Shimada, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2008
Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphomaNoriko Shimasaki, Tetsuya Mori, Chiharu Torii, et al.
European Journal of Clinical Pharmacology|October 30, 2007
Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazoleAi Mihara, Takehiko Mori, Yoshinobu Aisa, et al.
Cancer Science|June 23, 2018
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance dataTakahisa Kawamura, Hidefumi Kasai, Valentina Fermanelli, et al.
Oncology Research|October 8, 2009
Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transportKohji Takara, Toshiyuki Sakaeda, Mikio Kakumoto, et al.
The Journal of Pharmacy and Pharmacology|March 21, 2002
Simvastatin and lovastatin, but not pravastatin, interact with MDR1Toshiyuki Sakaeda, Kohji Takara, Mikio Kakumoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 31, 2022
Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trialsEisuke Booka, Chiyo K Imamura, Masashi Takeuchi, et al.
Bone|July 26, 2011
A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind studyToshio Matsumoto, Masako Ito, Yasufumi Hayashi, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasoneYuki Otani, Yunqi Zhao, Guanyu Wang, et al.
Genetic Testing|June 10, 2005
Comprehensive screening of the thiopurine methyltransferase polymorphisms by denaturing high-performance liquid chromatographyToru Udaka, Chiharu Torii, Daisuke Takahashi, et al.
Pageof 10